While it has been in research for over 20 years, it has recently gained a second life thanks to the massive public interest in peptide therapy and the rise of GLP-1 medications.
It is believed to engage with various cellular signaling routes to manifest its actions
The RxPepsDirect starting dose is 20 units (0.6 mg) per injection on a U-100 syringe drawn from a 15 mg/3 mL vial
CJC-1295/Ipamorelin is typically discussed where the goal is: improved recovery from training or overuse reduced recovery capacity poor sleep affecting healing age-related decline in muscle repair post-injury rehabilitation and rebuilding performance optimisation In practical terms, it is framed around the bodys recovery system needs support. Why they are treated differently The distinction comes down to mechanism and treatment intent
The GHK-Cu dosage protocol examples below cover 1.0 mg, 1.5 mg, and 2.0 mg amounts, with matching U-100 syringe units, reconstitution steps, supplies, and research context
Molecular Profile Peptide: AOD-9604 Type: GH fragment (176191) analogue Sequence Length: 15 amino acids Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Gly-Phe-Tyr-Ser-OH Molecular Weight: ~ 1,813 Da Form: Lyophilized powder Purity: 98% (HPLC tested) Storage & Stability Store lyophilized peptide at 20C Protect from heat, moisture, and light Reconstituted solutions should be used promptly or stored per laboratory protocol Avoid repeated freeze-thaw cycles What the Research Shows About AOD-9604 & Cartilage 1
.jpg)
